SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Momenta Pharmaceuticals Inc.
An SI Board Since March 2004
Posts SubjectMarks Bans Symbol
3027 64 0 MNTA
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1677Nice find, Idit. p.s. For some reason, your quotation marks came out as questiDewDiligence_on_SI-4/24/2008
1676<b>MIT-led teams unravel heparin death mystery</b> eurekalert.org idos-4/24/2008
1675>I respectfully disagree< Time will tell. >I thought you were still oidos-4/22/2008
1674>>Hasn't the FDA been allowing such inter-batch variability in Sanofi&IRWIN JAMES FRANKEL-4/22/2008
1673Hasn't the FDA been allowing such inter-batch variability in Sanofi's entuck-4/22/2008
1672<i>>the fact that GENZ, with all its experience, is having trouble persDewDiligence_on_SI-4/22/2008
1671The FDA are very careful, not to say conservative. EMEA on the other hand, stateidos-4/22/2008
1670Myozme isn't a generic but this is representative of how difficult it is to rkrw-4/22/2008
1669A formal response to the FDA’s generic-Lovenox concerns will be submitted in earDewDiligence_on_SI-4/22/2008
1668>>Also, an appellate court decision on enoxaparin -the generic name of LovIRWIN JAMES FRANKEL-4/21/2008
1667>>UPDATE: Novartis' Generic Lovenox Launch In 2008 Still Possible Lasttuck-4/21/2008
1666Further to the same topic: siliconinvestor.comDewDiligence_on_SI-4/21/2008
1665Novel Oral Anticoagulant Pradaxa(R) (dabigatran etexilate) Approved by the Europnigel bates-4/21/2008
1664SI jumped 700K in half a month: From 4.4M to 5.1M nasdaqtrader.comIRWIN JAMES FRANKEL-4/9/2008
1663Thanks, ij (eom).DewDiligence_on_SI-4/8/2008
1662Link to decisions by the Federal Circuit: cafc.uscourts.gov I think this is whIRWIN JAMES FRANKEL-4/8/2008
1661Momenta Pharmaceuticals Announces Presentation of M118 Phase 1 Results At the AmIRWIN JAMES FRANKEL-4/4/2008
1660I briefly looked at it and they were partnered with APPX who is very credible burkrw-4/1/2008
1659Yes, it’s synthetic. I haven’t followed the Aussie company enough to know what tDewDiligence_on_SI-4/1/2008
1658Off hand, I think arixtra is synthetic but very complicated. It may not be so earkrw-4/1/2008
1657That pretty well sums up the Arixtra situation. The last 3-year H-W period expirDewDiligence_on_SI-4/1/2008
1656Arixtra changed hands once or twice, patent is expired I think, maybe it was jusrkrw-4/1/2008
1655<i>>Arixtra, a synthetic drug that is marketed by GlaxoSmithKline and cDewDiligence_on_SI-4/1/2008
1654More focus on Altus, but mentions of heparin, arixtra, surfactan.... nytimes.corkrw-4/1/2008
1653Amphastar and Teva submitted separate Lovenox ANDA’s in 2003—before the Dec03 chDewDiligence_on_SI-3/28/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News